GovBidAlerts
← All opportunities

Keyence Fluorescence Microscope

Key dates

Posted
May 22, 2026
Response deadline
Jun 1, 2026, 1:00 PM UTC
Archive date
Archive type
auto15

Classification

Notice type
Presolicitation
Base type
Presolicitation
Set-aside
No Set aside used
Set-aside code
NONE
PSC
6525

NAICS

Issuing office

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Office code
075.7529.75N980
Organization type
OFFICE
Office address
BETHESDA, MD, 20892, USA

Place of performance

Street
Street 2
City
Itasca
State
Illinois
Zip
60143
Country
UNITED STATES

Contacts

Description

General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00438 Posted Date: May 22, 2026 Original Response Date: June 1, 2026 Current Response Date: June 1, 2026 Set Aside: N/A NAICS Code: 423830 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Keyence Corporation of America 500 Park Boulevard Suite 200 Itasca IL 60143 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 423830 . REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Keyence Fluorescence Microscope Background Information: The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency conducting and supporting medical discoveries that improve people’s health and save lives. The National Institutes of Health Undiagnosed Diseases Program (UDP) is a program designed to address the needs of persons with debilitating medical conditions for which no diagnosis has been found despite an extensive workup. The goals of the UDP include finding accurate diagnoses and discovering new diseases that provide insight into human physiology and genetics. The UDP was established to evaluate participants who have undiagnosed medical conditions. UDP participants have generally received extensive diagnostic workups before traveling to the NIH and often have numerous and/or complex medical problems. The UDP program makes use of a diverse set of diagnostic and research techniques both to attempt to find a diagnosis and to generate research projects to advance medical knowledge. Cells from admitted Undiagnosed Disease patients will be used to perform necessary biological laboratory experiments to determine the mechanism of the patients’ disease. he Keyence BZ-X1000 fluorescence microscope package including the stitch multi-point image and Z-stacking modules, along with 2X, 10X, 20X, and 40X fluorite phase or apochromat objectives and the BZX analyzer software will allow the laboratory to perform necessary high-sensitivity cellular experiments and analysis to determine the cellular mechanisms involved in patient genetic mutations.. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by June 1, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00438. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”

Similar open contracts

Metadata

Notice ID
027a3b036dde490e8f05b24279595c09
Full path
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO
Office code
075.7529.75N980
Ingested
May 23, 2026
Updated
Jun 15, 2026